SCHEMBL4012445

SCHEMBL4012445

CC(C)(C)OC(=O)N1CCC(Nc2cc(C(=O)O)nc(Cl)n2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
NPC1 O15118 1/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CNR1 P21554 3/20 0.45
NSD2 O96028 1/20 0.45
CCNT1 O60563 1/20 0.45
GPR119 Q8TDV5 3/20 0.44
EPHX1 P07099 1/20 0.44
STS P08842 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
SYK P43405 1/20 0.43
PRMT5 O14744 1/20 0.43
BRD4 O60885 1/20 0.43
USP30 Q70CQ3 1/20 0.42
MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1748149 0.90 ALDH1A1 (0.51) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL1748497 0.88 ALDH1A1 (0.54) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL21777558 0.88 USP30 (0.48) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL21777561 0.88 USP30 (0.48) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL1748206 0.87 ALDH1A1 (0.53) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL27172313 0.86 ALDH1A1 (0.54) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL29999549 0.86 ALDH1A1 (0.54) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL27172465 0.85 GPR119 (0.49) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL30000268 0.85 GPR119 (0.49) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL1748420 0.85 ALDH1A1 (0.51) ALDH1A1NPC1MAPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118339154-B Salt of heterocyclic antitumor compound and crystal form thereof 石药集团中奇制药技术(石家庄)有限公司 2026-05-19 CN disclosed
EP-4631939-A1 SALT AND CRYSTAL FORM OF ANTI-TUMOR HETEROCYCLIC COMPOUND CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) 2025-10-15 EP disclosed
CN-118339154-A Salt of heterocyclic antitumor compound and crystal form thereof 石药集团中奇制药技术(石家庄)有限公司 2024-07-12 CN disclosed
EP-4339193-A1 COMPOUND HAVING ANTI-TUMOR ACTIVITY AND USE THEREOF Innovstone Therapeutics Limited (CN) 2024-03-20 EP disclosed
WO-2022237858-A1 COMPOUND HAVING ANTI-TUMOR ACTIVITY AND USE THEREOF 上海翊石医药科技有限公司 2022-11-17 WO disclosed
CN-115340528-A Compound with anti-tumor activity and application thereof 上海翊石医药科技有限公司 2022-11-15 CN disclosed
EP-2044054-A2 PYRIMIDINE AND QUINAZOLINE DERIVATIVES AS MODULATORS OF SOMATOSTATINE RECEPTOR ACTIVITY F. Hoffmann-Roche AG (CH) 2009-04-08 EP disclosed
WO-2008000692-A2 PYRIMIDINE AND QUINAZOLINE DERIVATIVES AS MODULATORS OF SOMATOSTATINE RECEPTOR ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed